Valuation: Bayer AG

Market Cap 46.95B 925B 54.36B 44.12B 40.12B 75.44B 5,198B 76.68B 517B 202B 2,603B 204B 200B 8,650B P/E 2026 *
20.2x
P/E 2027 * 15.4x
Enterprise Value 76.14B 1,500B 88.16B 71.55B 65.07B 122B 8,430B 124B 838B 328B 4,221B 331B 324B 14,028B EV / Sales 2026 *
1.67x
EV / Sales 2027 * 1.58x
Free-Float
99.99%
Yield 2026 *
0.33%
Yield 2027 * 1.11%
1 day+17.09%
1 month+17.09%
3 months+16.67%
6 months-2.63%
Current year+18.69%
1 month 912.16
Extreme 912.16
912.16
Current year 746.83
Extreme 746.83
1,009.21
1 year 600
Extreme 600
1,009.21
3 years 395
Extreme 395
1,009.21
5 years 395
Extreme 395
1,449.8
10 years 395
Extreme 395
2,669.55
Manager TitleAgeSince
Chief Executive Officer 60 2023-05-31
Director of Finance/CFO 57 2026-05-31
Chief Tech/Sci/R&D Officer 59 2021-01-31
Director TitleAgeSince
Director/Board Member 56 2012-03-31
Director/Board Member 60 2017-03-31
Chairman 68 2020-04-27
Change 5-day change 1-year change 3-year change Capi.($)
+17.09%-.--% - - 54.36B
-2.25%-0.47%+72.43%+119.36% 1,052B
-0.66%+0.43%+49.01%+50.11% 627B
-0.54%+1.39%+21.88%+63.83% 441B
-1.99%-3.32%+41.98%+34.08% 349B
-1.05%-2.81%+24.22%+34.67% 287B
-2.12%-3.67%-1.09%+3.11% 241B
-0.63%+1.04%+43.03%+59.10% 224B
-1.19%-3.41%-9.18%-52.41% 202B
+0.16%+3.87%+16.25%+73.27% 172B
Average +1.12%+0.43%+28.73%+42.79% 399.46B
Weighted average by Cap. +0.17%+0.32%+41.31%+62.03%

Financials

2026 *2027 *
Net sales 45.7B 900B 52.92B 42.95B 39.06B 73.43B 5,060B 74.64B 503B 197B 2,534B 199B 194B 8,420B 46.9B 924B 54.31B 44.08B 40.08B 75.36B 5,193B 76.6B 516B 202B 2,600B 204B 199B 8,642B
Net income 2.18B 43.02B 2.53B 2.05B 1.87B 3.51B 242B 3.57B 24.05B 9.4B 121B 9.49B 9.29B 402B 2.94B 57.92B 3.4B 2.76B 2.51B 4.72B 326B 4.8B 32.38B 12.66B 163B 12.78B 12.51B 542B
Net Debt 29.19B 575B 33.8B 27.43B 24.95B 46.9B 3,232B 47.68B 321B 126B 1,618B 127B 124B 5,378B 26.96B 531B 31.21B 25.33B 23.04B 43.32B 2,985B 44.03B 297B 116B 1,495B 117B 115B 4,967B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,830
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
47.79EUR
Average target price
56.92EUR
Spread / Average Target
+19.10%

Quarterly revenue - Rate of surprise